Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Clinical trial NCT04079179 · RECRUITING

Trial details

NCT number: NCT04079179
Sponsor: Carl Allen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Langerhan's Cell Histiocytosis Juvenile Xanthogranuloma Erdheim-Chester Disease Rosai Dorfman Disease Neuro-Degenerative Disease Histiocytic Sarcoma Histiocytic Disorders, Malignant

Start date: 2021-04-19
Primary completion: 2025-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.